Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
Recent Share tips:
- Avoid Robinson (RBN) by Steve Moore in ShareProphets
- Buy Kingfisher (KGF) by Mark Tovey in The Motley Fool
- Hold WPP (WPP) by Edmond Jackson in Interactive Investor
- Sell Ra International Group (RAI) by Steve Moore in ShareProphets
- Buy Seed Innovations Limited (SEED) by Tom Winnifrith in Hot Stock Rockets
- Buy Bluebird Merchant Ventures (DI) (BMV) by Tom Winnifrith in Hot Stock Rockets
- Long Term Buy BP (BP.) by Michelle Freeman in The Motley Fool
- Buy Headlam Group (HEAD) by Tom Winnifrith in ShareProphets
- Avoid Hostmore (MORE) by Steve Moore in ShareProphets
- Hold BT Group (BT.A) by Chris Bailey in ShareProphets
- Hold Johnson Matthey (JMAT) by Chris Bailey in ShareProphets
- Avoid Auto Trader Group (AUTO) by Chris Bailey in ShareProphets
- Outperform Sage Group (SGE) by Credit Suisse
- Underperform Auto Trader Group (AUTO) by Credit Suisse
- Buy Johnson Matthey (JMAT) by Berenberg
- Long Term Buy Rio Tinto (RIO) by Dr. James Fox in The Motley Fool
- Long Term Buy Crest Nicholson Holdings (CRST) by Dr. James Fox in The Motley Fool
- Long Term Buy Aviva (AV.) by Dr. James Fox in The Motley Fool
- Long Term Buy Synthomer (SYNT) by Dr. James Fox in The Motley Fool
- Long Term Buy Vistry Group (VTY) by Dr. James Fox in The Motley Fool
Immupharma (IMM)
Health Care Sector
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Immupharma Overview
ImmuPharma PLC is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor is the company's most advanced drug in development and is a treatment for lupus, a life threatening autoimmune disease and has now completed dosing Lupus patients in its Phase III pivotal trial. This is only part of our story as our scientists and researchers are developing drugs to make life changing difference to peoples lives worldwide.Latest Immupharma Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Northland Capital | – | 2018-04-17 16:35:00 17/04/2018 | – |
| – | Paul Summers | – | 2018-03-01 09:50:00 01/03/2018 | – |
| – | FinnCap | – | 2017-12-21 11:30:00 21/12/2017 | – |
| – | FinnCap | – | 2017-12-12 08:00:00 12/12/2017 | – |
| – | Harvey Jones | – | 2017-10-09 15:30:00 09/10/2017 | – |
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Immupharma Overview
ImmuPharma PLC is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor is the company's most advanced drug in development and is a treatment for lupus, a life threatening autoimmune disease and has now completed dosing Lupus patients in its Phase III pivotal trial. This is only part of our story as our scientists and researchers are developing drugs to make life changing difference to peoples lives worldwide.Latest Immupharma Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Northland Capital | – | 2018-04-17 16:35:00 17/04/2018 | – |
| – | Paul Summers | – | 2018-03-01 09:50:00 01/03/2018 | – |
| – | FinnCap | – | 2017-12-21 11:30:00 21/12/2017 | – |
| – | FinnCap | – | 2017-12-12 08:00:00 12/12/2017 | – |
| – | Harvey Jones | – | 2017-10-09 15:30:00 09/10/2017 | – |